CASTLE BIOSCIENCES INC CSTL

Rank #2029 · Nasdaq · $1.1B market cap

⚠ Going-concern flag — the auditor (KPMG LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

35.9

P/E

-19.6

P/B

2.82

ROE

-14.4%

Op. Margin

-30.9%

Debt Ratio

19%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Weak

P/E -19.6x, P/B 2.82x. Ranks in the top 64% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -14.4%. Ranks in the top 82% of the universe.

Safety ★★★★☆

Excellent

Debt ratio 19%. Ranks in the top 13% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★★

Excellent

Revenue growth of 60.4% year over year. Ranks in the top 6% of the universe.

Growth is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2019	$0.0B	$-0.0B	$-0.0B	$-0.1B	-16.8	-65
2020	$0.1B	$0.0B	$0.0B	$-0.1B	14.1	-61
2021	$0.1B	$-0.0B	$-0.0B	$0.1B	-10.4	28
2022	$0.1B	$-0.0B	$-0.0B	$0.4B	-42.6	12
2023	$0.1B	$-0.1B	$-0.1B	$0.4B	-53.2	12
2024	$0.1B	$-0.1B	$-0.1B	$0.4B	-53.2	15
2025	$0.2B	$-0.1B	$-0.1B	$0.4B	-30.9	19

← See the full screener